These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11716475)

  • 1. Polarized expression of the GFP-tagged rat V(1a) vasopressin receptor.
    Campos DM; Reyes CE; Sarmiento J; Navarro J; González CB
    Biochem Biophys Res Commun; 2001 Nov; 289(2):325-8. PubMed ID: 11716475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate.
    Conway BR; Minor LK; Xu JZ; D'Andrea MR; Ghosh RN; Demarest KT
    J Cell Physiol; 2001 Dec; 189(3):341-55. PubMed ID: 11748592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the green fluorescent protein-tagged inositol 1,4,5-trisphosphate receptor type 3 in Ca(2+) release and entry in DT40 B lymphocytes.
    Morita T; Tanimura A; Nezu A; Kurosaki T; Tojyo Y
    Biochem J; 2004 Sep; 382(Pt 3):793-801. PubMed ID: 15175012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist.
    Gunnet JW; Wines P; Xiang M; Rybczynski P; Andrade-Gordon P; de Garavilla L; Parry TJ; Cheung WM; Minor L; Demarest KT; Maryanoff BE; Damiano BP
    Eur J Pharmacol; 2008 Aug; 590(1-3):333-42. PubMed ID: 18599033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
    Zhao H; Hart LL; Keller U; Holth LT; Davie JR
    J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL receptor-GFP fusion proteins: new tools for the characterisation of disease-causing mutations in the LDL receptor gene.
    Holst HU; Dagnaes-Hansen F; Corydon TJ; Andreasen PH; Jørgensen MM; Kølvraa S; Bolund L; Jensen TG
    Eur J Hum Genet; 2001 Nov; 9(11):815-22. PubMed ID: 11781697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking pathways of Cx49-GFP in living mammalian cells.
    Breidert S; Jacob R; Ngezahayo A; Kolb HA; Naim HY
    Biol Chem; 2005 Feb; 386(2):155-60. PubMed ID: 15843159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional enhanced green fluorescent protein (EGFP)-tagged angiotensin II at(1a) receptor recruits the endogenous Galphaq/11 protein to the membrane and induces its specific internalization independently of receptor-g protein coupling in HEK-293 cells.
    Miserey-Lenkei S; Lenkei Z; Parnot C; Corvol P; Clauser E
    Mol Endocrinol; 2001 Feb; 15(2):294-307. PubMed ID: 11158335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarized cell surface expression of the green fluorescent protein-tagged vasopressin V2 receptor in Madin Darby canine kidney cells.
    Schülein R; Lorenz D; Oksche A; Wiesner B; Hermosilla R; Ebert J; Rosenthal W
    FEBS Lett; 1998 Dec; 441(2):170-6. PubMed ID: 9883878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable polarized expression of hCAT-1 in an epithelial cell line.
    Cariappa R; Heath-Monnig E; Furesz TC; Kamath SG; Smith CH
    J Membr Biol; 2002 Mar; 186(1):23-30. PubMed ID: 11891586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-type voltage-gated Ca(2+) channel interacts with synaptic proteins and recruits synaptotagmin to the plasma membrane of Xenopus oocytes.
    Cohen R; Atlas D
    Neuroscience; 2004; 128(4):831-41. PubMed ID: 15464290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial dynamics of GFP-tagged proteins investigated by local fluorescence enhancement.
    Yokoe H; Meyer T
    Nat Biotechnol; 1996 Oct; 14(10):1252-6. PubMed ID: 9631088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
    Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
    Vascul Pharmacol; 2007 Jun; 46(6):463-9. PubMed ID: 17395547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type 3 inositol 1,4,5-trisphosphate receptor is concentrated at the tight junction level in polarized MDCK cells.
    Colosetti P; Tunwell RE; Cruttwell C; Arsanto JP; Mauger JP; Cassio D
    J Cell Sci; 2003 Jul; 116(Pt 13):2791-803. PubMed ID: 12759372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice.
    Morita M; Kita Y; Morikawa N; Iwami M; Notsu Y
    Exp Clin Endocrinol Diabetes; 2001; 109(5):261-6. PubMed ID: 11507649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity.
    Oksche A; Leder G; Valet S; Platzer M; Hasse K; Geist S; Krause G; Rosenthal A; Rosenthal W
    Mol Endocrinol; 2002 Apr; 16(4):799-813. PubMed ID: 11923476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.